Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment.

@article{Brunswick2002FluoxetineAN,
  title={Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment.},
  author={David J. Brunswick and Jay D. Amsterdam and Jan Fawcett and Frederic M. Quitkin and Frederick W Reimherr and Jerrold F. Rosenbaum and Charles M. Beasley},
  journal={Journal of affective disorders},
  year={2002},
  volume={68 2-3},
  pages={243-9}
}
BACKGROUND Virtually no attention has been given to the relationship between antidepressant plasma drug concentrations and relapse-prevention during maintenance therapy. The purpose of this study was to investigate the relationship between steady-state plasma drug concentrations and outcome during relapse-prevention therapy with fluoxetine. METHODS The… CONTINUE READING